These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF. Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W J Nucl Med; 2000 Nov; 41(11):1830-5. PubMed ID: 11079490 [TBL] [Abstract][Full Text] [Related]
3. Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression? Rabiner EA; Bhagwagar Z; Gunn RN; Cowen PJ; Grasby PM Neuropsychopharmacology; 2004 Sep; 29(9):1688-98. PubMed ID: 15127080 [TBL] [Abstract][Full Text] [Related]
4. On the quantification of [18F]MPPF binding to 5-HT1A receptors in the human brain. Passchier J; van Waarde A; Vaalburg W; Willemsen AT J Nucl Med; 2001 Jul; 42(7):1025-31. PubMed ID: 11438622 [TBL] [Abstract][Full Text] [Related]
5. Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats. Passchier J; van Waarde A; Doze P; Elsinga PH; Vaalburg W Eur J Pharmacol; 2000 Nov; 407(3):273-80. PubMed ID: 11068023 [TBL] [Abstract][Full Text] [Related]
6. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus. Zimmer L; Rbah L; Giacomelli F; Le Bars D; Renaud B J Nucl Med; 2003 Sep; 44(9):1495-501. PubMed ID: 12960198 [TBL] [Abstract][Full Text] [Related]
7. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. Costes N; Merlet I; Ostrowsky K; Faillenot I; Lavenne F; Zimmer L; Ryvlin P; Le Bars D J Nucl Med; 2005 Dec; 46(12):1980-9. PubMed ID: 16330560 [TBL] [Abstract][Full Text] [Related]
8. EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. McAllister-Williams RH; Massey AE Psychopharmacology (Berl); 2003 Mar; 166(3):284-93. PubMed ID: 12589521 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of 5-HT1A receptor ligands by drug discrimination. Wolff MC; Leander JD Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023 [TBL] [Abstract][Full Text] [Related]
10. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561 [TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397 [TBL] [Abstract][Full Text] [Related]
12. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. Zimmer L; Mauger G; Le Bars D; Bonmarchand G; Luxen A; Pujol JF J Neurochem; 2002 Jan; 80(2):278-86. PubMed ID: 11902118 [TBL] [Abstract][Full Text] [Related]
13. Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography. Andrée B; Thorberg SO; Halldin C; Farde L Psychopharmacology (Berl); 1999 Jun; 144(3):303-5. PubMed ID: 10435400 [TBL] [Abstract][Full Text] [Related]
14. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development. Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260 [TBL] [Abstract][Full Text] [Related]
15. 5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study. Lothe A; Boni C; Costes N; Bouvard S; Gorwood P; Lavenne F; Alvarez M; Ryvlin P Behav Brain Funct; 2010 Jul; 6():37. PubMed ID: 20609217 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907 [TBL] [Abstract][Full Text] [Related]
17. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy. Derry C; Benjamin C; Bladin P; le Bars D; Tochon-Danguy H; Berkovic SF; Zimmer L; Costes N; Mulligan R; Reutens D Neuroimage; 2006 Apr; 30(2):341-8. PubMed ID: 16275016 [TBL] [Abstract][Full Text] [Related]
18. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674 [TBL] [Abstract][Full Text] [Related]
19. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists. Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290 [TBL] [Abstract][Full Text] [Related]
20. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]